A guide to COVID‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS‐CoV‐2 infection
DK Brady, AR Gurijala, L Huang, AA Hussain… - The FEBS …, 2024 - Wiley Online Library
Antiviral therapies are integral in the fight against SARS‐CoV‐2 (ie severe acute respiratory
syndrome coronavirus 2), the causative agent of COVID‐19. Antiviral therapeutics can be …
syndrome coronavirus 2), the causative agent of COVID‐19. Antiviral therapeutics can be …
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
S Kakavandi, B Hajikhani, P Azizi, F Aziziyan… - Cell Communication and …, 2024 - Springer
Extensive research in countries with high sociodemographic indices (SDIs) to date has
shown that coronavirus disease 2019 (COVID-19) may be directly associated with more …
shown that coronavirus disease 2019 (COVID-19) may be directly associated with more …
Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2
M Upadhyay, S Gupta - Virus Research, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has recently emerged throughout the world …
syndrome coronavirus 2 (SARS-CoV-2), has recently emerged throughout the world …
Computational screening of plant-derived natural products against SARS-CoV-2 variants
The present study explores the efficacy of plant-derived natural products (PDNPs) against
spike glycoproteins (S-glycoprotein) of SARS-CoV-2 variants using molecular docking …
spike glycoproteins (S-glycoprotein) of SARS-CoV-2 variants using molecular docking …
Inhibition potential of natural flavonoids against selected omicron (B. 1.19) mutations in the spike receptor binding domain of SARS-CoV-2: A molecular modeling …
Abstract The omicron (B. 1.19) variant of contagious severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is considered a variant of concern (VOC) due to its increased …
coronavirus 2 (SARS-CoV-2), is considered a variant of concern (VOC) due to its increased …
A top-down approach for studying the in-silico effect of the novel phytocompound tribulusamide B on the inhibition of Nipah virus transmission through targeting fusion …
D Rababi, A Nag - Computational Biology and Chemistry, 2024 - Elsevier
The proteins of Nipah virus ascribe to its lifecycle and are crucial to infections caused by the
virus. In the absence of approved therapeutics, these proteins can be considered as drug …
virus. In the absence of approved therapeutics, these proteins can be considered as drug …
A single antiviral for a triple epidemic: is it possible?
Aim: A triple epidemic of respiratory syncytial virus (RSV), SARS-CoV-2 and influenza
variants is on the rise worldwide. It is crucial to identify antiviral agents that can be used …
variants is on the rise worldwide. It is crucial to identify antiviral agents that can be used …
[Retracted] A Bioinformatic Approach Based on Systems Biology to Determine the Effects of SARS‐CoV‐2 Infection in Patients with Hypertrophic Cardiomyopathy
X Han, F Wang, P Yang, B Di, X Xu… - … Methods in Medicine, 2022 - Wiley Online Library
Recently, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative
agent of coronavirus disease 2019 (COVID‐19), has infected millions of individuals …
agent of coronavirus disease 2019 (COVID‐19), has infected millions of individuals …
SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research
W Souza Rocha, P Zhan… - Current Topics in …, 2023 - ingentaconnect.com
The Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome Coronavirus 2 (SARS-CoV-2), has resulted in millions of deaths and threatens …
syndrome Coronavirus 2 (SARS-CoV-2), has resulted in millions of deaths and threatens …
[HTML][HTML] In Silico Studies of Drug Discovery and Design Against COVID-19 Focusing on ACE2 and Spike Protein Virus Receptors: A Systematic Review
The emergence of COVID-19 has prompted researchers worldwide to focus on developing
drugs that specifically target ACE2 receptors and SARS-CoV-2 Spike Protein receptors …
drugs that specifically target ACE2 receptors and SARS-CoV-2 Spike Protein receptors …